DESOUZA ERROL B received a stock award from CYCLERION THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 12/4/2023ACC: 0000950170-23-067736
Director
Since Apr 2021
+50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
50K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
66.7%
11/30/2023
30K→50K
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
New position
11/30/2023
0.00→30K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/30/2023 | A · Award | +20K | — | — | 66.7% | 30K | 50K |
| Common Stock Direct | 11/30/2023 | A · Award | +30K | — | — | New position | 0.00 | 30K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported